China’s New mRNA Covid Vaccine Targeting Omicron Starts Trial Production

[ad_1] Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA technology to target new variants of Covid-19 that are behind the country’s current outbreak. [ad_2] Source link

China-Developed mRNA Covid Vaccine Starts Test Production

[ad_1] Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA Technology to target new variants of Covid-19 that are behind the country’s current outbreak. [ad_2] Source link

Corporate Insiders Aren’t Betting on a Market Rebound

[ad_1] Markets Stocks Recent market declines have pushed stock prices lower, but executives and directors haven’t been scooping up their companies’ shares [ad_2] Source link

Opinion | Covid Is China’s Price for Rejoining Humanity

[ad_1] Beijing botches a ‘reopening’ that many of its Pacific neighbors pulled off gracefully. [ad_2] Source link

Moderna’s mRNA Cancer Vaccine Shows Promise in Preliminary Study

[ad_1] Business Health Care Health The shot combined with a Merck immunotherapy reduced the risk of relapse in people with skin cancer in a study, Moderna said [ad_2] Source link